Mitigation of risk of botulinum toxin A-induced blepharoptosis with hyperconcentrated glabellar injections.
Autor: | Ghanian S; Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island; Division of Dermatology, College of Medicine, University of Arizona, Tucson, Arizona., Wambier SPF; Ophthalmology and Oculoplastic Surgery, Wambier Center of Medical Specialties, Ponta Grossa, Brazil., Wambier CG; Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island. Electronic address: carlos_wambier@brown.edu. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jun; Vol. 90 (6), pp. 1309-1310. Date of Electronic Publication: 2023 Dec 25. |
DOI: | 10.1016/j.jaad.2023.12.025 |
Abstrakt: | Competing Interests: Conflicts of interest Dr Wambier has served as a board advisor for Allergan and has served as a speaker for Galderma. Drs Ghanian and Wambier have no conflict of interest to disclose. |
Databáze: | MEDLINE |
Externí odkaz: |